SCHEMBL29470959

SCHEMBL29470959

CCCCCCCCCCCCCCN(CCCCCCCCCCCCCC)CC(N)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 4/20 0.44
CES1 P23141 4/20 0.44
SOAT1 P35610 2/20 0.44
MEN1 O00255 1/20 0.44
FAAH O00519 1/20 0.44
TP53 P04637 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C19 P33261 1/20 0.44
KMT2A Q03164 1/20 0.44
KDM5A P29375 2/20 0.42
PHF8 Q9UPP1 2/20 0.42
KDM4C Q9H3R0 1/20 0.42
DNM1 Q05193 4/20 0.41
KDM4E B2RXH2 2/20 0.40
ICMT O60725 1/20 0.39
ALB P02768 1/20 0.39
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA9 Q16790 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13270009 1.00 CES2 (0.44) CES2CES1SOAT1MEN1FAAH
SCHEMBL3753980 1.00 CES2 (0.44) CES2CES1SOAT1MEN1FAAH
SCHEMBL4210961 1.00 CES2 (0.44) CES2CES1SOAT1MEN1FAAH
SCHEMBL28869538 1.00 CES2 (0.44) CES2CES1SOAT1MEN1FAAH
SCHEMBL28420309 0.98 CES2 (0.42) CES2CES1SOAT1MEN1FAAH
SCHEMBL15809341 0.96 CES2 (0.41) CES2CES1SOAT1MEN1FAAH
SCHEMBL25509010 0.96 KDM5A (0.44) CES2CES1SOAT1MEN1FAAH
SCHEMBL8386144 0.94 CES2 (0.39) CES2CES1SOAT1MEN1FAAH
SCHEMBL1777056 0.91 CA1 (0.46) CES2CES1SOAT1MEN1FAAH
SCHEMBL8383111 0.89 KDM5A (0.41) CES2CES1SOAT1MEN1FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114787127-A Ionizable lipids and nanoparticle compositions thereof 世代生物公司 2022-07-22 CN disclosed
CN-114127044-A Ionizable amine lipids and lipid nanoparticles 英特利亚治疗股份有限公司 2022-03-01 CN disclosed